Funder
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,Molecular Medicine
Reference19 articles.
1. Institute for Clinical and Economic Review. Modulator treatments for cystic fibrosis: effectiveness and value. 2020. https://icer.org/wp-content/uploads/2020/08/ICER_CF_Final_Report_092320.pdf. Accessed 7 Jan 2023.
2. Office of Representative Katie Porter. Skyrocketing: how big pharma exploits launch pricest to cash in on cancer. 2020. https://porter.house.gov/uploadedfiles/skyrocketing_-_how_big_pharma_exploits_launch_prices_to_cash_in_on_cancer.pdf. Accessed 7 Jan 2023.
3. Prasad V, De Jesus K, Mailankody S. The high price of anticancer drugs: origins, implications, barriers, solutions. Nat Rev Clin Oncol. 2017;14:381–90.
4. Dusetzina SB, Huskamp HA, Rothman RL, Pinheiro LC, Roberts AW, Shah ND, et al. Many Medicare beneficiaries do not fill high-price specialty drug prescriptions. Health Aff. 2022;41:487–96.
5. Yabroff KR, Dowling EC, Guy GP Jr., Banegas MP, Davidoff A, Han X, et al. Financial hardship associated with cancer in the united states: findings from a population-based sample of adult cancer survivors. J Clin Oncol. 2016;34:259–67.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献